Ma, Tao
Yang, Shunfu
Gao, Yan
Wu, Xinxin
Li, Si
Yan, Dan
He, Jigang
Funding for this research was provided by:
The National Natural Science Foundation of China (82060299)
Medical discipline Leader Project of Yunnan Provincial Health Commission (D-2019020)
Yunnan Provincial Government's Ten Thousand Talents Plan-Youth Top Talents Project (KH-SWR-QNBJ-2019-002)
Clinical Medical Center of the first People's Hospital of Yunnan Province (2022LCZXKF-HX05)
Kunming Medical Joint Project-Outstanding Youth Training Project (202101AY070001-034)
Yunnan First People's Hospital Clinical Medicine Center Open Project (2022LCZXKF-HX05)
Kunming Medical Union Special Project-General Project (202101AY070001-272)
Kunming Medical Joint Special Project-General Project Yunnan Province "Xingdian Talent Support Plan" Famous Medical Special Project (XDYC-MY-2022-0037)
Article History
Received: 22 August 2025
Accepted: 7 January 2026
First Online: 29 January 2026
Declarations
:
: Our study was approved by the Medical Ethics Committee of The First People’s Hospital of Yunnan Province. All datasets in the present study were downloaded from public databases, including GSEA, GEO, GO, KEGG, STRING, MSigDB and StarBase database. These public databases allowed researchers to download and analyse public datasets for scientific purposes. Thus, the use of public database data in this study was reviewed and exempted by the Medical Ethics Committee of The First People’s Hospital of Yunnan Province. The current research follows the GSEA, GEO, GO, KEGG, STRING, MSigDB and StarBase data access policies and publication guidelines. GSEA, GEO, GO, KEGG, STRING, MSigDB and StarBase belong to public databases. The patients involved in the database have obtained ethical approval. Users can download relevant data for free for research and publish relevant articles. Our study is based on open-source data, so there are no ethical issues and other conflicts of interest. And the animal experiments with the assistance of Yunnan Labreal Biotech Co., Ltd., the animal experiment was conducted and received approval from the Experimental Animal Ethics Committee of Yunnan Labreal Biotech Co., Ltd (IACUC Issue No. PZ20221003) and complied with ARRIVE Guidelines 2.0.
: The authors declare no competing interests.